Skip to main content
SpringerLink
Log in

Overdiagnosis, Underdiagnosis, Synthesis: A Dialectic for Psychiatry and the DSM

  • Chapter
  • First Online:
Making the DSM-5

Abstract

Defining the borders of mental illness is challenging due to the lack of established validity for psychiatric disorders, a diagnostic system based largely on reported symptoms, and the highly subjective nature of distress and functional impairment. Consequently, debates about the potential perils of overdiagnosis (e.g., false positives) and underdiagnosis (e.g., false negatives) with new diagnostic revisions are ongoing as we prepare for the release of DSM-5. Such debates are rooted in the many different and often conflicting applications of psychiatric diagnosis, with clinical work generally favoring lowered diagnostic thresholds on the one hand and the work of rationing of healthcare resources necessitating higher thresholds on the other. Deciding what should or should not be considered a mental disorder in DSM can only be resolved by a pragmatic analysis of contextual utility. A philosophically satisfying, scientifically grounded, and economically viable model of future psychiatry should more formally acknowledge a continuum of mental illness and mental health, apply research evidence-based guidelines regarding optimal interventions along this continuum rather than assuming pharmacotherapy is a panacea, and concede that specialty care provided by psychiatrists must be integrated within the larger scope of mental health care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pies R. How “objective” are psychiatric diagnoses? (guess again). Psychiatry. 2007;4:18–22.

    PubMed  Google Scholar 

  2. Frances A. A warning sign on the road to DSM-5: beware of unintended consequences. Psychiatric Times [Internet]. 26 Jun 2009 [cited 1 Aug 2012]. www.psychiatrictimes.com/display/article/10168/1425378.

  3. Frances A. Opening Pandora’s box: the 19 worst suggestions for DSM5. Psychiatric Times [Internet]. 11 Feb 2010 [cited 1 Aug 2012]. http://www.psychiatrictimes.com/dsm/content/article/10168/1522341.

  4. Angell M. The illusions of psychiatry. New York Review of Books [Internet]. 14 Jul 2011 [cited 1 Aug 2012]. http://www.nybooks.com/articles/archives/2011/jul/14/illusions-of-psychiatry Accessed 1 July 2012.

  5. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983–7.

    PubMed  CAS  Google Scholar 

  6. First MB, Pincus HA, Levine JB, Williams JBW, Ustun B, Peele R. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry. 2004;161:946–54.

    Article  PubMed  Google Scholar 

  7. Pierre JM. Deconstructing schizophrenia for DSM-5: challenges for clinical and research agendas. Clin Schizophr Relat Psychoses. 2008;2:166–74.

    Article  Google Scholar 

  8. Pierre JM. The borders of mental illness in psychiatry and the DSM: past, present, and future. J Psychiatr Pract. 2010;16:375–86.

    Article  PubMed  Google Scholar 

  9. Pierre JM. Mental illness and mental health: is the glass half empty or half full? Can J Psychiatry. 2012;57(11):651–8.

    PubMed  Google Scholar 

  10. Double D. The limits of psychiatry. BMJ. 2002;324:900–4.

    Article  PubMed  Google Scholar 

  11. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ. 2002;324:886–91.

    Article  PubMed  Google Scholar 

  12. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62:593–602.

    Article  PubMed  Google Scholar 

  13. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62:617–27.

    Article  PubMed  Google Scholar 

  14. Moffitt TE, Caspie A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010;40:899–909.

    Article  PubMed  CAS  Google Scholar 

  15. Smith R. In search of “non-disease”. BMJ. 2002;324:883–5.

    Article  PubMed  Google Scholar 

  16. Grob GN. Origins of DSM-I: a study in appearance and reality. Am J Psychiatry. 1991;148:421–31.

    PubMed  CAS  Google Scholar 

  17. Grob GN. The forging of mental health policy in America: World War II to new frontier. J Hist Med Allied Sci. 1987;42:410–46.

    Article  PubMed  CAS  Google Scholar 

  18. Ghaemi SN. Nosologomania: DSM & Karl Jaspers’ critique of Kraepelin. Philos Ethics Humanit Med. 2009;4:10.

    Article  PubMed  Google Scholar 

  19. Menninger K. The vital balance: the life process in mental health and illness. New York: Viking; 1963.

    Google Scholar 

  20. Shorter E. A history of psychiatry: from the era of the asylum to the age of Prozac. New York: Wiley; 1997.

    Google Scholar 

  21. Horwitz A. Creating mental illness. Chicago: The University of Chicago Press; 2002.

    Google Scholar 

  22. Double DB. What would Adolf Meyer have thought of the neo-Kraepelinian approach? Psychiatr Bull. 1990;14:472–4.

    Article  Google Scholar 

  23. Meyer A. The mental hygiene movement. Can Med Assoc J. 1918;8:632–4.

    PubMed  CAS  Google Scholar 

  24. Cohen S. The mental hygiene movement, the development of personality and the school: the medicalization of American education. Hist Educ Q. 1983;23:123–49.

    Article  PubMed  CAS  Google Scholar 

  25. The Committee on Nomenclature and Statistics of the American Psychiatric Association. Diagnostic and statistical manual: mental disorders. Washington, DC: American Psychiatric Association; 1952.

    Google Scholar 

  26. Wilson M. DSM-III and the transformation of American psychiatry: a history. Am J Psychiatry. 1993;150:399–410.

    PubMed  CAS  Google Scholar 

  27. Spitzer RL, Williams JBW. American psychiatry’s transformation following the publication of DSM-III. Am J Psychiatry. 1994;151(3):459–60.

    PubMed  CAS  Google Scholar 

  28. Horwitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. Oxford: Oxford University Press; 2007.

    Google Scholar 

  29. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? J Clin Psychiatry. 2008;69(6):935–40.

    Article  PubMed  Google Scholar 

  30. Patten SB. Does almost everyone suffer from a bipolar disorder? Can J Psychiatry. 2006; 51:6–8.

    PubMed  Google Scholar 

  31. Patten SB, Paris J. The bipolar spectrum—a bridge too far? Can J Psychiatry. 2008; 53:762–8.

    PubMed  Google Scholar 

  32. Duffy A. Does bipolar disorder exist in children? A selected review. Can J Psychiatry. 2009; 52:409–17.

    Google Scholar 

  33. Spitzer RL, First MB, Wakefield JC. Saving PTSD from itself in DSM-5. J Anxiety Disord. 2007;21:233–41.

    Article  PubMed  Google Scholar 

  34. Rosen GM, Taylor S. Pseudo-PTSD. J Anxiety Disord. 2007;21:201–10.

    Article  PubMed  Google Scholar 

  35. Wakefield JC, Horwitz AV, Schmitz MF. Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective. Can J Psychiatry. 2005;50:317–9.

    PubMed  Google Scholar 

  36. Lane C. Shyness: how normal behavior became a sickness. New Haven: Yale University Press; 2007.

    Google Scholar 

  37. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord. 2007;11:106–13.

    Article  PubMed  Google Scholar 

  38. King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38:1224–34.

    Article  PubMed  Google Scholar 

  39. Balon R. The DSM, criteria for sexual dysfunction: need for a change. J Sex Marital Ther. 2008;34:186–7.

    Article  PubMed  Google Scholar 

  40. Moser C, Kleinplatz PJ. DSM-IV-TR and the paraphilias: an argument for removal. J Psychol Human Sex. 2005;17:91–109.

    Article  Google Scholar 

  41. Miller G, Holden C. Proposed revisions to psychiatry’s canon unveiled. Science. 2010; 327:770–1.

    Article  PubMed  CAS  Google Scholar 

  42. Wakefield JC. Diagnosing DSM-IV—Part 1: DSM-IV and the concept of disorder. Behav Res Ther. 1997;35(7):633–49.

    Article  PubMed  CAS  Google Scholar 

  43. Wakefield JC. The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry. 2007;6:149–56.

    PubMed  Google Scholar 

  44. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: an experiential approach to behavioral change. New York: The Guilford Press; 1999.

    Google Scholar 

  45. Szasz TS. The myth of mental illness: foundations of a theory of personal conduct, revised edition. New York: Harper and Row; 1974.

    Google Scholar 

  46. Rosenhan DL. On being sane in insane places. Science. 1973;179:250–8.

    Article  PubMed  CAS  Google Scholar 

  47. Kendell RE, Cooper JE, Gourlay AJ, Copeland JR, Sharpe L, Gurland BJ. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry. 1971;25:123–30.

    Article  PubMed  CAS  Google Scholar 

  48. Kendell RE. Psychiatric diagnosis in Britain and the United States. Br J Psychiatry. 1975;9:453–61.

    Google Scholar 

  49. Pagura J, Katz LY, Mojtabai R, Druss BG, Cox B, Sareen J. Antidepressant use in the absence of common mental disorders in the general population. J Clin Psychiatry. 2011; 72(4):494–501.

    Article  PubMed  Google Scholar 

  50. Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database. J Clin Psychopharmacol. 2002;22(1):40–5.

    Article  PubMed  Google Scholar 

  51. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.

    Article  PubMed  Google Scholar 

  52. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level metaanalysis. JAMA. 2010;303(1):46–53.

    Article  Google Scholar 

  53. Kass LR. Beyond therapy: biotechnology and the pursuit of happiness. http://biotech.law.lsu.edu/research/pbc/reports/beyondtherapy/beyond_therapy_final_report_pcbe.pdf. Accessed 1 July 2012.

  54. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, et al. Neurocognitive enhancement: what can we do and what should we do? Nature Rev. 2004;5:421–5.

    CAS  Google Scholar 

  55. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:702–5.

    Article  PubMed  CAS  Google Scholar 

  56. Larriviere D, Williams MA, Rizzo M, et al. Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee. Neurology. 2009;73:1406–12.

    Article  PubMed  Google Scholar 

  57. Hirschfield RMA, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277(4):333–40.

    Article  Google Scholar 

  58. Coyne JC, Schwenk TL, Fechner-Bates S. Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiatry. 1995;17:3–12.

    Article  PubMed  CAS  Google Scholar 

  59. Rost K, Zhang M, Fortney J, Smith J, Coyne J, Smith GR. Persistently poor outcomes of undetected major depression in primary care. Gen Hosp Psychiatry. 1998;20:12–20.

    Article  PubMed  CAS  Google Scholar 

  60. Angermeyer MC, Matschinger H, Riedel-Heller SG. Whom to ask for help in case of a mental disorder? Preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol. 1999;34(4):202–10.

    Article  PubMed  CAS  Google Scholar 

  61. Aoun S, Pennebaker D, Wood C. Assessing population need for mental health care: a review of approaches and predictors. Ment Health Serv Res. 2004;6(10):33–46.

    Article  PubMed  Google Scholar 

  62. Magruder KM, Calderone GE. Public health consequences of different thresholds for the diagnosis of mental disorders. Compr Psychiatry. 2000;41(2 Suppl 1):14–8.

    Article  PubMed  CAS  Google Scholar 

  63. Helmchen H, Linden M. Subthreshold disorders in psychiatry: clinical reality, methodologic artifact, and the double-threshold problem. Compr Psychiatry. 2000;41(2 Suppl 1):1–7.

    Article  PubMed  CAS  Google Scholar 

  64. Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, et al. Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J Affect Dis. 2003;76:171–81.

    Article  PubMed  Google Scholar 

  65. Kessler RC, Merikangas KR, Berglund P, Eaton WM, Koretz DS, Walters EE. Mild disorders should not be eliminated from the DSM-V. Arch Gen Psychiatry. 2003;60:1117–22.

    Article  PubMed  Google Scholar 

  66. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 survey’s estimates. Arch Gen Psychiatry. 2002;59:115–23.

    Article  PubMed  Google Scholar 

  67. Schulze B. Stigma and mental health professionals: a review of the evidence on an intricate relationship. Int Rev Psychiatry. 2007;19(20):137–55.

    Article  PubMed  Google Scholar 

  68. Henderson C, Thornicroft G. Stigma and discrimination in mental illness: time to change. Lancet. 2009;373:1928–30.

    Article  PubMed  Google Scholar 

  69. Sartorius N. Stigma: what can psychiatrists do about it? Lancet. 1998;352:1058–9.

    Article  PubMed  CAS  Google Scholar 

  70. Kaysen S. Girl, interrupted. New York: Turtle Bay Books; 1993.

    Google Scholar 

  71. Mattisson C, Bogren M, Nettelbladt P, Munk-Jorgensen P, Bhugra D. First incidence ­depression in the Lundby Study: a comparison of the two time periods 1947-1972 and 1972-1997. J Affect Disord. 2005;87:151–60.

    Article  PubMed  Google Scholar 

  72. Eaton WW, Kalaydjian A, Scharfstein DO, Mezuk B, Ding Y. Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981–2004.

    Google Scholar 

  73. Robins LN, Helzer JE, Weismann MM, Orvaschel H, Gruenberg E, Burke Jr JD, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949–58.

    Article  PubMed  CAS  Google Scholar 

  74. Regier DA, Kaelber CT, Rae DS, Farmer ME, Knauper B, Kessler RC, et al. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch Gen Psychiatry. 1998;55:109–55.

    Article  PubMed  CAS  Google Scholar 

  75. Pies R. The ideal and the real: how does psychiatry escape the DSM-5 “Fly-bottle?”. Bull Assoc Adv Philos Psychiatry. 2010;17(2):18–22.

    Google Scholar 

  76. Spitzer RL, Wakefield JC. DSM-IV diagnostic criteria for clinical significance: does it help solve the false positives problem? Am J Psychiatry. 1999;156:1856–64.

    PubMed  CAS  Google Scholar 

  77. Pierre JM. Mental disorder vs. normality: defining the indefinable. Bull Assoc Adv Philos Psychiatry. 2010;17(20):9–11.

    Google Scholar 

  78. Frances A. Problems in defining clinical significance in epidemiologic studies. Arch Gen Psychiatry. 1998;55:119.

    Article  PubMed  CAS  Google Scholar 

  79. van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45:11–20.

    Article  PubMed  Google Scholar 

  80. Insel T, Cuthbert B, Garvey M, et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–50.

    Article  PubMed  Google Scholar 

  81. Pincus HA, Frances A, Davis WW, First MB, Widiger TA. DSM-IV and new diagnostic categories: holding the line on proliferation. Am J Psychiatry. 1992;149:112–7.

    PubMed  CAS  Google Scholar 

  82. Goldman HH, Grob GN. Defining “mental illness” in mental health policy. Heal Aff. 2006;25(3):737–49.

    Article  Google Scholar 

  83. Substance Abuse and Mental Health Services Administration. Final notice establishing definitions for (1) children with a serious emotional disturbance, and (2) adults with a serious mental illness. Fed Regist. 1993;58:29422–5.

    Google Scholar 

  84. Ustun B, Kennedy C. What is “functional impairment”? Disentangling disability from clinical significance. World Psychiatry. 2009;8:82–5.

    PubMed  Google Scholar 

  85. Spitzer RL. Diagnosis and need for treatment are not the same. Arch Gen Psychiatry. 1998;55:120.

    Article  PubMed  CAS  Google Scholar 

  86. Mechanic D. Is the prevalence of mental disorders a good measure of the need for services? Heal Aff. 2003;22(5):8–20.

    Article  Google Scholar 

  87. First M, Halon R. Use of DSM paraphilia diagnoses in sexually violent predator commitment cases. J Am Acad Psychiatry Law. 2008;36:443–54.

    PubMed  Google Scholar 

  88. First M, Frances A. Issues of DSM-IV: unintended consequences of small changes: the case of paraphilias. Am J Psychiatry. 2008;165:1240–1.

    Article  PubMed  Google Scholar 

  89. Green R. Is pedophilia a mental disorder? Arch Sexual Behav. 2002;31:467–71.

    Article  Google Scholar 

  90. Maj M. Are we able to differentiate between true mental disorders and homestatic reactions to adverse life events? Psychother Psychsom. 2007;76:257–9.

    Article  Google Scholar 

  91. Philips J, Frances A, Cerullo M, Chardavoyne J, First M, Ghaemi N, et al. The six most essential questions in psychiatric diagnosis: a pluralogue part 2: issues of conservatism and pragmatism in psychiatric diagnosis. Philos Ethics Humanit Med. 2012;7:8.

    Article  Google Scholar 

  92. Kupfer DJ, Dr. Kupfer defends DSM-5. Medscape psychiatry [Internet]. 1 Jun 2012 [cited 1 Aug 2012]. http://www.medscape.com/viewarticle/764735.

  93. McMahon DM. Happiness: a history. New York: Atlantic Monthly Press; 2006.

    Google Scholar 

  94. Mojtabai R. Americans’ attitudes towards psychiatric medications: 1998-2006. Psychiatr Serv. 2009;60:1015–23.

    Article  PubMed  Google Scholar 

  95. Pierre JM. Final comment. Bull Assoc Adv Philos Psychiatry. 2010;17(20):12–3.

    Google Scholar 

  96. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33(30):665–72.

    Article  PubMed  Google Scholar 

  97. Correll CU, Hauser M, Auther AM, et al. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry. 2010;51(40):390–431.

    Article  PubMed  Google Scholar 

  98. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Probably at-risk, but certainly ill—advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res. 2010; 120:23–37.

    Article  PubMed  Google Scholar 

  99. Morrison AP, French P, Stewart SLK, Birchwood M, Fowler D, Gumley AI, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomized controlled study. BMJ. 2012;344:e2233.

    Article  PubMed  Google Scholar 

  100. Woods SW, Walsh BC, Saksa JR, et al. The case for including attenuated psychotic symptoms syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res. 2010;123:199–207.

    Article  PubMed  Google Scholar 

  101. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69(3):220–9.

    Article  PubMed  Google Scholar 

  102. Yung AR, Phillips LJ, Nelson B, et al. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry. 2011; 72(4):430–40.

    Article  PubMed  Google Scholar 

  103. Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res. 2010;116:168–72.

    Article  PubMed  Google Scholar 

  104. McGorry PD. Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res. 2010;120:49–53.

    Article  PubMed  Google Scholar 

  105. Corcoran CM, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res. 2010;120:16–22.

    Article  PubMed  Google Scholar 

  106. Yang LH, Wonpat-Borja AJ, Opler MG, et al. Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question. Schizophr Res. 2010;120:42–8.

    Article  PubMed  CAS  Google Scholar 

  107. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921–8.

    Article  PubMed  Google Scholar 

  108. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163:790–9.

    Article  PubMed  Google Scholar 

  109. Cornblatt BA. The New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Genet. 2002;114:956–66.

    Article  PubMed  Google Scholar 

  110. Amminger GP, Schäfer MR, Papageorgiou K, et al. Longchain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo- controlled trial. Arch Gen Psychiatry. 2010;67:146–54.

    Article  PubMed  CAS  Google Scholar 

  111. Morrison AP, French P, Walford L, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomized, controlled trial. Br J Psychiatry. 2004;185:291–7.

    Article  PubMed  Google Scholar 

  112. Walker EF, Cornblatt BA, Addington J, et al. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodromal Longitudinal Sample. Schizophr Res. 2009;115:50–7.

    Article  PubMed  Google Scholar 

  113. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull. 2009;35:841–3.

    Article  PubMed  Google Scholar 

  114. Helzer JW, Kraemer HC, Krueger RF, Wittchen HU, Sirovatka PJ, Regier DA, editors. Dimensional approaches in diagnostic classification: refining the research agenda for DSM-­V. Arlington, VA: American Psychiatric Association; 2007.

    Google Scholar 

  115. Frances A. How to avoid medicalizing normal grief in DSM5.Psychiatric Times [Internet]. 16 Mar 2010 [cited 1 Aug 2012]. http://www.psychiatrictimes.com/topics/content/article/10168/1538825.

  116. Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PPS, et al. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41(8):1751–61.

    Article  PubMed  CAS  Google Scholar 

  117. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry. 2007;164(6):859–60.

    Article  PubMed  Google Scholar 

  118. Batstra L, Frances A. Diagnostic inflation: causes and a suggested cure. J Nerv Ment Dis. 2012;6:474–9.

    Article  Google Scholar 

  119. Stein DJ, Philips KS, Bolton D, Fulford KWM, Sadler JZ, Kendler KS. What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med. 2010;40:1759–65.

    Article  PubMed  CAS  Google Scholar 

  120. First MB, Wakefield JC. Defining ‘mental disorder’ in DSM-V. Psychol Med. 2010;40:1779–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Joseph M. Pierre

  2. VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

    Joseph M. Pierre

Authors
  1. Joseph M. Pierre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph M. Pierre .

Editor information

Editors and Affiliations

  1. Jewish General Hospital, Department of Psychiatry, Sir Mortimer B. Davis, Côte Ste. Catherine Road 4333, Montreal, H3T1E4, Québec, Canada

    Joel Paris

  2. , Department of Psychiatry, Yale School of Medicine, Noble Avenue 88, New Haven, 06460, Connecticut, USA

    James Phillips

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pierre, J.M. (2013). Overdiagnosis, Underdiagnosis, Synthesis: A Dialectic for Psychiatry and the DSM. In: Paris, J., Phillips, J. (eds) Making the DSM-5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6504-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6504-1_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6503-4

  • Online ISBN: 978-1-4614-6504-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation